FILING ANALYSIS · WEDNESDAY, OCTOBER 21
ABBOTT LABORATORIES ABT — 8-K: Results of Operations and Financial Condition
positive
Abbott Laboratories reported strong third-quarter results with 14.5% sales growth and reaffirmed its full-year adjusted diluted EPS guidance, driven by balanced growth across its portfolio and new product approvals.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →